🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In patients with gunshot wounds during hostilities in Ukraine, 76.9% have n...
Status
Completed
Location
Bogomolets National Medical University, Ministry of Health of Ukraine
Start Date
2022-02-24
Trial ID
NCT05482061
Treatments Being Tested
This study is to collect and validate regulatory-grade real-world data (RWD...
Status
Completed
Location
Teton Cancer Institute
Start Date
2021-05-05
Trial ID
NCT04028479
Treatments Being Tested
The goal of the this observational study is to gather clinically available ...
Status
Recruiting
Location
University Hospital Basel, Department of Cardiology
Start Date
2021-06-10
Trial ID
NCT05662293
The aim of this study is to evaluate the impact of Ibrutinib monotherapy in...
Status
Completed
Location
Fundaleu
Start Date
2019-08-12
Trial ID
NCT04016636
Treatments Being Tested
Less than 10% of patients eliciting out-of-hospital cardiac arrest (OHCA) s...
Status
Recruiting
Location
Angers University Hospital, Medical Intensive Care Unit, Vent'Lab
Start Date
2025-06-11
Trial ID
NCT07028372
This is a prospective, longitudinal, observational study designed to charac...
Status
Not Yet Recruiting
Location
Centre de référence des maladies neuromusculaire, Centre Hospitalier Régional de la Citadelle
Start Date
2026-08
Trial ID
NCT07201636
The aim of this study is to provide baseline acute otitis media data in Eas...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-06
Trial ID
NCT01365390
Treatments Being Tested
The purpose of this study is to describe the 2-year retention rate of ibrut...
Status
Completed
Location
Ospedali Riuniti Di Ancona
Start Date
2018-10-30
Trial ID
NCT03720561
Treatments Being Tested
The BIOMArCS-AAA study aims to investigate the associations of (temporal pa...
Status
Unknown
Location
Erasmus Medical Center
Start Date
2017-03-23
Trial ID
NCT03703947
30% of patients with epilepsy suffer from drug-resistant seizures and are a...
Status
Recruiting
Location
Hôpital Pierre Wertheimer
Start Date
2024-11-04
Trial ID
NCT06545214